EuroIntervention PCRonline - Connecting with the community

Just accepted article

Combined Erythropoietin and Iron Therapy for Anemic Patients Undergoing Transcatheter Aortic Valve Replacement: The EPICURE Randomized Clinical Trial

Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.

Sign in to download the full article

1. Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 2. Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 3. Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 4. Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 5. Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 6. Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 7. Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 8. Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 9. Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 10. Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 11. Department of Cardiac Surgery, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 12. Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 13. Department of Hematology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; 14. CANADA

Abstract

Aims: To evaluate, in anemic patients, the efficacy of erythropoietin (EPO) in reducing red-cell transfusion rates after transcatheter aortic valve replacement (TAVR).

Methods and results: This was a randomiz…

– OR –